back to homepage

Mergers & Acquisitions

MRC Technology Sells Its Melanocortin Receptors Programme To Pfizer Inc. (PFE)

London, June 18, 2014: MRC Technology, a technology transfer organisation, announced today that it has sold to Pfizer Inc. its melanocortin receptors (MCRs) programme, which includes a set of small

Read More

Catalyst Pharmaceutical Partners Set to Join Russell Microcap(R) Index

CORAL GABLES, Fla., June 18, 2014.  Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on developing safe and effective approved medicines targeting orphan neuromuscular and neurological diseases, announced

Read More

Merrimack Pharma Raises $77 Million in Private Financing

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel treatments for cancer, today announced that it has raised $77 million in a Series G private

Read More

Sanford-Burnham Collaborates with Ortho-McNeil-Janssen

Sanford-Burnham Medical Research Institute (Sanford-Burnham) has entered into a collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., (OMJPI) to discover compounds for Alzheimer’s disease and major psychiatric disorders.

Read More